Update on utilities and cost-utility analyses.
OBJECTIVE
The purpose of this review is to summarize the recent and noteworthy utility studies and cost-utility analyses in the area of retina/vitreous during the period January 2004 to January 2006.


RESULTS
This review considers the cost-effectiveness of treatments for wet age-related macular degeneration, dry age-related macular degeneration, telemedicine in diabetic retinopathy, and utilities and patients with age-related macular degeneration and diabetic retinopathy.


CONCLUSIONS
Utilities are being used increasingly to measure health-related quality of life. Cost-utility analyses are becoming more readily available for comparing the incremental cost-effectiveness of different ophthalmic interventions.
Hollands
Hussein
H
Cost-effective Ocular Health Policy Unit, Queens University, Kingston, Ontario, Canada.
Sharma
Sanjay
S
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D008268:Macular Degeneration / Q000191:economics*